William S Sly Selected Research

Lysosomal Storage Diseases (Lysosomal Storage Disease)

3/2016	Pharmacologic manipulation of lysosomal enzyme transport across the blood-brain barrier.
2/2015	First human treatment with investigational rhGUS enzyme replacement therapy in an advanced stage MPS VII patient.
1/2015	Alpha Adrenergic Induction of Transport of Lysosomal Enzyme across the Blood-Brain Barrier.
9/2014	Morquio A syndrome: diagnosis and current and future therapies.
10/2013	Human β-glucuronidase: structure, function, and application in enzyme replacement therapy.
3/2013	Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII.
10/2012	Biochemical evidence for superior correction of neuronal storage by chemically modified enzyme in murine mucopolysaccharidosis VII.
9/2012	Long circulating enzyme replacement therapy rescues bone pathology in mucopolysaccharidosis VII murine model.
4/2010	New strategies for enzyme replacement therapy for lysosomal storage diseases.
6/2008	Infused Fc-tagged beta-glucuronidase crosses the placenta and produces clearance of storage in utero in mucopolysaccharidosis VII mice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William S Sly Research Topics

Disease

20	Mucopolysaccharidosis VII (Sly Syndrome) 01/2016 - 11/2002
16	Neoplasms (Cancer) 01/2017 - 07/2002
16	Lysosomal Storage Diseases (Lysosomal Storage Disease) 03/2016 - 03/2003
12	Mucopolysaccharidoses 02/2015 - 12/2003
11	Hemochromatosis (Bronze Diabetes) 06/2008 - 01/2002
6	Mucopolysaccharidosis IV (Morquio Syndrome) 02/2015 - 12/2003
5	Retinitis Pigmentosa (Pigmentary Retinopathy) 04/2018 - 04/2004
4	Hypoxia (Hypoxemia) 08/2017 - 03/2004
3	Colorectal Neoplasms (Colorectal Cancer) 09/2016 - 09/2007
3	Glioblastoma (Glioblastoma Multiforme) 06/2012 - 04/2008
2	Glaucoma 04/2018 - 03/2013
2	Cystic Fibrosis (Mucoviscidosis) 08/2017 - 01/2016
2	Congenital Abnormalities (Deformity) 02/2015 - 01/2007
2	Intellectual Disability (Idiocy) 02/2015 - 01/2007
2	Body Weight (Weight, Body) 02/2015 - 03/2008
2	Hyperammonemia 03/2014 - 04/2013
2	Hypophosphatasia 03/2014 - 07/2006
2	Mucopolysaccharidosis III (Sanfilippo Syndrome) 10/2012 - 07/2008
2	Astrocytoma (Pilocytic Astrocytoma) 06/2012 - 04/2008
2	Carcinogenesis 09/2007 - 05/2006
1	Eye Diseases (Eye Disease) 04/2018
1	Back Pain (Backache) 08/2017
1	Wasting Syndrome (Wasting Disease) 08/2017
1	Craniosynostoses (Craniosynostosis) 01/2017
1	Osteomalacia 01/2017
1	Rickets (Rachitis) 01/2017
1	Wounds and Injuries (Trauma) 01/2017
1	Hyponatremia 01/2016
1	Rare Diseases (Rare Disease) 01/2016
1	Lung Diseases (Lung Disease) 01/2016
1	Failure to Thrive 01/2016
1	Coarse facial features 02/2015
1	Bone Diseases (Bone Disease) 02/2015
1	Umbilical Hernia (Omphalocele) 02/2015
1	Infections 02/2015
1	Respiratory Insufficiency (Respiratory Failure) 02/2015
1	Skin Neoplasms (Skin Cancer) 09/2014
1	Pyruvate Carboxylase Deficiency Disease 03/2014
1	Dehydration (Water Stress) 01/2014
1	Obesity 03/2013
1	Nervous System Diseases (Neurological Disorders) 03/2013
1	Malignant Mesothelioma 03/2013
1	Mucopolysaccharidosis I (Hurler Syndrome) 03/2013
1	Developmental Bone Diseases (Bone Dysplasia) 03/2013

Drug/Important Bio-Agent (IBA)

26	EnzymesIBA 01/2017 - 03/2003
17	GlucuronidaseIBA 01/2016 - 11/2002
14	Carbonic Anhydrases (Carbonic Anhydrase)IBA 04/2018 - 07/2003
11	IronIBA 06/2008 - 01/2002
10	GlycosaminoglycansIBA 01/2016 - 08/2004
10	IsoenzymesIBA 01/2014 - 07/2002
6	Biomarkers (Surrogate Marker)IBA 08/2017 - 08/2004
6	SulfatasesIBA 09/2014 - 12/2003
5	Proteins (Proteins, Gene)FDA Link 04/2008 - 03/2002
4	Protein Isoforms (Isoforms)IBA 04/2018 - 04/2008
4	Keratan SulfateIBA 03/2013 - 12/2003
4	Carbonic Anhydrase IVIBA 04/2010 - 04/2004
3	Carbonic Anhydrase IXIBA 03/2013 - 09/2007
3	Carbonic Anhydrase IIIBA 05/2010 - 07/2002
3	HepcidinsIBA 06/2008 - 11/2002
3	Transferrin Receptors (Transferrin Receptor)IBA 06/2008 - 08/2002
3	Protein Sorting Signals (Signal Peptide)IBA 12/2007 - 04/2004
3	Dietary IronIBA 08/2002 - 01/2002
2	Estrogen ReceptorsIBA 08/2017 - 05/2008
2	Carbon DioxideIBA 01/2017 - 02/2015
2	Glucuronic Acid (Glucuronate)IBA 01/2016 - 01/2013
2	Heparitin Sulfate (Heparan Sulfate)IBA 02/2015 - 03/2013
2	Chondroitin Sulfates (Chondroitin Sulfate)IBA 02/2015 - 02/2003
2	Alkaline PhosphataseIBA 03/2014 - 07/2006
2	Pharmaceutical PreparationsIBA 03/2013 - 09/2011
2	SulfonamidesIBA 03/2013 - 03/2013
2	N-sulfoglucosamine sulfohydrolase (sulfamidase)IBA 10/2012 - 07/2008
2	carbonic anhydrase XIIIBA 05/2008 - 04/2008
2	Messenger RNA (mRNA)IBA 04/2008 - 09/2007
2	Complementary DNA (cDNA)IBA 08/2004 - 08/2004
2	Transferrin (beta 2 Transferrin)IBA 08/2002 - 03/2002
1	CarbonIBA 04/2018
1	SaltsIBA 08/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Protons (Proton)IBA 01/2017
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2017
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2017
1	AntibodiesIBA 09/2016
1	ChloridesIBA 01/2016
1	Dermatan SulfateIBA 02/2015
1	Oxygen (Dioxygen)IBA 02/2015
1	Urea (Carbamide)FDA LinkGeneric 03/2014
1	carglumic acid FDA Link 03/2014
1	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 03/2014
1	AmmoniaIBA 04/2013
1	Blood Glucose (Blood Sugar)IBA 04/2013
1	DiureticsIBA 03/2013
1	Anti-Ulcer AgentsIBA 03/2013
1	Antiglaucoma AgentsIBA 03/2013
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 03/2013

Therapy/Procedure

12	Enzyme Replacement Therapy 03/2016 - 03/2004
4	Therapeutics 02/2015 - 06/2012
1	Sutures (Suture) 01/2017
1	Tracheostomy 02/2015
1	Investigational Therapies (Experimental Therapy) 02/2015
1	Continuous Positive Airway Pressure 02/2015